glp-1 and eye disease The Benefits Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review Ozempic Blindness: Should You Worry?

The 38-year-old information technology worker from New Mexico had a prescription

Shes urging patients to be patient if theyre trying to get new prescriptions under the Bridge program

This is precisely the domain where in silico approaches are most mature and regulatory agencies have the most experience accepting submissions

"Interindividual variability in response to medications to treat addiction has always been true and will continue to be true with GLP-1s," Lembke said

How Far We Need to Go

Possible reasons include Type 1 diabetes diagnosis, advanced Type 2 diabetes with severely depleted beta cells, contraindication to GLP-1 drugs (thyroid cancer history, pancreatitis history), insurance or cost barriers, prior GLP-1 intolerance, or very high blood sugar requiring immediate insulin coverage